NPCE NeuroPace Inc: Aggregate Business Assets

This chart of total asset price changes for NeuroPace, Inc. (NPCE), valued at 101.54, is based on a steady inflow of funds from loyal neurostimulator users. NeuroPace, Inc. (NPCE) acts as a pioneer in creating AI-powered smart implants to combat epilepsy. However, expansion rates are hindered by medical insurance complexities and colossal R&D costs amid a fierce struggle for technological leadership.

NeuroPace Corp (NPCE) Company Total Assets: for the period 07/04/2022 - 10/28/2026

Financial and market metric breakdowns for NeuroPace Corp (NPCE)

- price and consensus price forecast:

Market Price neuropace.com|NPCE - Consensus Target

- market capitalization data:

Market Value NeuroPace Medical|NPCE - Enterprise Value

- book capitalization data:

Accounting Value of a Share NeuroPace|NPCE - Book Capitalization|Market-to-Book Ratio neuropace.com|NPCE - Aggregate Company Assets

- debt and liquidity data:

All Debt to Shareholders' Equity Ratio NeuroPace, Inc.|NPCE - Long-Term Debt to Capital|Short-Term Debt to Capital NeuroPace Medical|NPCE - Company Debts|Debts to Book Capitalization Ratio NeuroPace Medical

Fundamental company analysis:NeuroPace, Inc.

The credit quality assessment of NeuroPace, Inc. (NPCE) is based on an analysis of its resource base and debt load. This indicator, calculated inversely via ROA, measures the total value of assets and liabilities to determine capital management efficiency. The stabilization of chip supplies and the expansion of the vendor pool optimize working capital, supporting asset stability. The dynamics of these fluctuations in total capital and liabilities signal scaling potential while maintaining operational efficiency.

Competing companies

Company Assets dexcom.com|Penumbra (PEN) - Cumulative Company Assets|Aggregate Business Assets Novanta Inc|Haemonetics Corp. (HAE) - Company Total Assets|Aggregate Asset Value Inspire Medical Systems Inc (INSP)|PRCT: Company Total Assets|conmed.com - Company Assets|Aggregate Company Assets Pulse Biosciences (PLSE)|INMD - Aggregate Asset Value|PMI: Company Total Assets|SRDX (Surmodics Inc.) - Company Total Assets|Aggregate Company Assets Senseonics Holdings Inc SENS|Total Asset Value of Company Tactile Systems Technology Inc.|SANUWAVE - Company Total Assets|Company Assets Outset Medical Inc OM|Cumulative Company Assets ELMD (Electromed)|LNSR - Company Total Assets|Cumulative Company Assets AVITA Medical, Inc. RCEL|PROF - Aggregate Business Assets|bairdmed.com - Company Total Assets|EDAP TMS (EDAP) - Company Total Asset Base|Company Total Assets APYX|Cumulative Company Assets IceCure Medical, Ltd. (ICCM)|Pulmonx Corporation (LUNG) - Cumulative Company Assets|Aggregate Asset Value TELA (telabio.com)|CytoSorbents Corporation - Aggregate Company Assets|Cumulative Company Assets Sensus Healthcare Inc SRTS|ZYXI (Zynex Inc) - Company Total Assets|ECOR - Company Assets|Company Total Assets vicarioussurgical.com|Inspira Technologies (IINN) - Total Business Assets|ICU: Company Total Assets|Company Total Asset Base IRIDEX Corp.|Company Total Assets INBS (Intelligent Bio Solutions)|Cumulative Company Assets beyondair.net (XAIR)|Company Total Assets PFSA (Profusa Inc)|STRATA Skin Sciences Inc. - Company Total Assets|GCTK - Aggregate Company Assets|nanovibronix.com (NAOV) - Aggregate Company Assets|Cumulative Company Assets Venus Concept Corp VERO|Nuwellis Corp (NUWE) - Aggregate Asset Value|Company Total Assets AEMD (Aethlon Medical)|Company Assets ASXC|AVGR: Aggregate Company Assets|Company Balance Sheet Assets BioSig Technologies BSGM|Cumulative Company Assets CUTR (Cutera, Inc)|Company Total Assets Know Labs Corporation KNW|Company Total Assets NARI (Inari Medical, Inc.)|NVRO: Company Total Asset Base|Aggregate Company Assets reshapelifesciences.com (RSLS)|SILK (Silk Road Medical, Inc.) - Total Asset Value of Company